HIV Scientific Papers

Reduced muscle quality is highly prevalent in aging People With HIV (PWH) and is associated with
excess visceral abdominal fat (EVAF)

2025

Author

Zachary Henry, Gary Sinclair, Karam Mounzer, Jordan E. Lake, John R. Koethe, James G. Terry, Sangeeta Nair, John J. Carr, Mohammed Zogheib, Christian Caldji, and Colleen S. McGary

High levels of treatment success seen with combined use of tesamorelin and GLP1-RAs in people
with HIV

2025

Author

Daniel Lee, Claudia Martorell, Edwin Calderon, Zachary Henry, Orin Douglas, Christian Caldji, Colleen S. McGary and Kaitlin Anstett

Cardiovascular Risk Scores and Insulin Resistance Are Higher With Excess Visceral Abdominal Fat in People With Hiv in the Modern Antiretroviral Era

2024

Author

K. MOUNZER , J.R. KOETHE , J.E. LAKE , M. ZOGHEIB , C.S. McGARY , B. CASH

Efficacy and Safety of 2 Fixed Doses of Ibalizumab Plus Optimized Background Regimen in
Treatment-Experienced HIV-Positive Individuals

2024

Author

Edwin DeJesus, MD, William J. Towner, Jr, MD, Joseph C Gathe, MD, R. Brandon Cash, PharmD, and Kaitlin Anstett, PhD

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) Study Design and Baseline Characteristics

2024

Author

Kumar, P. , Rolle, C., Henry, Z., Emu, B., Martorell, C., McKinnon, J., Slim, J., Cash, R. B. and Anstett, K., on behalf of the PROMISE-US Investigators

« ‹

› »

Theratechnologies Announces Completion of Acquisition by Future Pak. Click here to learn more.

Theratechnologies Announces Completion of Acquisition by Future Pak. Click here to learn more.